Aggarwal, V. A., & Hsu, D. H. (2014). Entrepreneurial Exits and Innovation.
- Ahuja, G. (2000). Collaboration networks, structural holes, and innovation: A longitudinal study. Administrative science quarterly, 45(3), 425-455, https://doi.org/10.2307/2667105.
Paper not yet in RePEc: Add citation now
Archibugi, D., Filippetti, A., Frenz, M. (2013b). The impact of the economic crisis on innovation: Evidence from Europe. Technological Forecasting and Social Change, 80 (7), 1247-1260, https://doi.org/10.1016/j.techfore.2013.05.005.
Baum, J. A., Calabrese, T., & Silverman, B. S. (2000). Dont go it alone: Alliance network composition and startups performance in Canadian biotechnology. Strategic management journal, 21(3), 267-294, https://doi.org/10.1002/(SICI)10970266 (200003)21:3<267::AID-SMJ89>3.0.CO;2-8.
Beaudry, C., & Schiffauerova, A. (2011). Impacts of collaboration and network indicators on patent quality: The case of Canadian nanotechnology innovation. European Management Journal, 29(5), 362-376, https://doi.org/10.1016/j.emj.2011.03.001.
- Bouncken, R. B., Fredrich, V., Ritala, P., & Kraus, S. (2018). Coopetition in new product development alliances: advantages and tensions for incremental and radical innovation. British Journal of Management, 29(3), 391-410, https://doi.org/10.1111/14678551.
Paper not yet in RePEc: Add citation now
Cantner, U., Meder, A. (2007). Technological proximity and the choice of cooperation partner. Journal of Economic Interaction and Coordination 2, 45-65.
Cefis, E., & Marsili, O. (2005). A matter of life and death: innovation and firm survival.
- Cohen, W. M., Levinthal, D. A. (1990). Absorptive capacity: A new perspective on learning and innovation. Administrative science quarterly, 128-152.
Paper not yet in RePEc: Add citation now
D’Agostino, L. M., & Moreno, R. (2018). Exploration during turbulent times: an analysis of the relation between cooperation in innovation activities and radical innovation performance during the economic crisis. Industrial and Corporate Change, 27(2), 387-412, https://doi.org/10.1093/icc/dtx035.
- Dean, T., Zhang, H., & Xiao, Y. (2020). The role of complexity in the Valley of Death and radical innovation performance. Technovation, 102160, https://doi.org/10.1016/j.technovation.2020.102160.
Paper not yet in RePEc: Add citation now
- Dunlap, D., Marion, T., & Friar, J. (2013). The role of cross-national knowledge on organizational ambidexterity: A case of the global pharmaceutical industry. Management Learning, https://doi.org/10.1177/1350507613480099.
Paper not yet in RePEc: Add citation now
- Dutta, D. K., & Hora, M. (2017). From invention success to commercialization success: Technology ventures and the benefits of upstream and downstream supply‐ chain alliances. Journal of Small Business Management, 55(2), 216-235, https://doi.org/10.1111/jsbm.12334.
Paper not yet in RePEc: Add citation now
- Filiou, D., & Golesorkhi, S. (2016). Influence of institutional differences on firm innovation from international alliances. Long Range Planning, 49(1), 129-144.
Paper not yet in RePEc: Add citation now
Gambardella, A., Harhoff, D., & Verspagen, B. (2008). The value of European patents. European Management Review, 5(2), 69-84, https://doi.org/10.1057/emr.2008.10.
- Häussler, C. (2007). Proactive versus reactive M&A activities in the biotechnology industry. The Journal of High Technology Management Research, 17(2), 109-123.
Paper not yet in RePEc: Add citation now
Hipp, A., & Binz, C. (2020). Firm survival in complex value chains and global innovation systems: Evidence from solar photovoltaics. Research Policy, 49(1), 103876.
Holmes, P., Hunt, A., & Stone, I. (2010). An analysis of new firm survival using a hazard function. Applied Economics, 42(2), 185-195, https://doi.org/10.1080/00036840701579234.
- Huang, H. C., Su, H. N., & Shih, H. Y. (2018). Analyzing patent transactions with patent-based measures. 2018 Portland international conference on management of engineering and technology (PICMET) (pp. 1-12). IEEE, https://doi.org/10.23919/PICMET.2018.8481871.
Paper not yet in RePEc: Add citation now
- Industrial and Corporate change, 14(6), 1167-1192, https://doi.org/10.1093/icc/dth081. Cohen, S. K., & Caner, T. (2016). Converting inventions into breakthrough innovations: The role of exploitation and alliance network knowledge heterogeneity.
Paper not yet in RePEc: Add citation now
- Jachno, K., Heritier, S., & Wolfe, R. (2021). Impact of a non-constant baseline hazard on detection of time-dependent treatment effects: a simulation study. BMC medical research methodology, 21(1), 1-15, https://doi.org/10.1186/s12874-021-01372-0.
Paper not yet in RePEc: Add citation now
- Kahl, J. (2015). The Determinants of Firm Growth in High-Technology Industries. An Empirical Analysis of Spatial, Relational and Institutional Factors in the German Biotechnology Industry. Schriftenreihe innovative betriebswirtschaftliche Forschung und Praxis, Band 443, Hamburg.
Paper not yet in RePEc: Add citation now
- Kim, C., & Song, J. (2007). Creating new technology through alliances: An empirical investigation of joint patents. Technovation, 27(8), 461-470, https://doi.org/10.1016/j.technovation.2007.02.007.
Paper not yet in RePEc: Add citation now
Levin, R. C., Klevorick, A. K., Nelson, R. R., Winter, S. G., Gilbert, R., & Griliches, Z. (1987). Appropriating the returns from industrial research and development. Brookings papers on economic activity, 1987(3), 783-831, https://doi.org/10.2307/2534454.
Li, Y., & Rizzo, J. A. (2020). Timing and payoff of patent purchases: the role of firm size and composition. Applied Economics, 52(54), 5894-5908, https://doi.org/10.1080/00036846.2020.1778159.
- Liu, E., & Lim, K. (2018). Using the Weibull accelerated failure time regression model to predict time to health events. BioRxiv, 362186, https://doi.org/10.1101/362186.
Paper not yet in RePEc: Add citation now
- On the way from invention to innovation: the role of applicant and inventor team characteristics Dahlin, K.B., Behrens, D.M. (2005). When is an invention really radical?: Defining and measuring technological radicalness. Research Policy, 34(5), 717-737, https://doi.org/10.1016/j.respol.2005.03.009.
Paper not yet in RePEc: Add citation now
- On the way from invention to innovation: the role of applicant and inventor team characteristics Hu, D., She, M., Ye, L., & Wang, Z. (2021). The more the merrier? Inventor team size, diversity, and innovation quality. Science and Public Policy, 48(4), 508–520, https://doi.org/10.1093/scipol/scab033.
Paper not yet in RePEc: Add citation now
- On the way from invention to innovation: the role of applicant and inventor team characteristics Schulz S., Passon A.M., Perleth M., Kulig M., Paschke N. & Matthias K. (2020) The evaluation of orphan drugs by the German Joint Federal Committee—an eight-year review. Dtsch Arztebl Int, 117, 868–9, https://doi.org/10.3238/arztebl.2020.0868.
Paper not yet in RePEc: Add citation now
Pajunen, K., Järvinen, J. (2018). To survive or succeed? An analysis of biotechnology firms, Small Business Economics, 51, 757-771. https://doi.org/10.1007/s11187-0179963 -6.
- S. (2018). Defining innovation with respect to new medicines: A systematic review from a payer perspective. International journal of technology assessment in health care, 34(3), 224-240, https://doi.org/10.1017/S0266462318000259.
Paper not yet in RePEc: Add citation now
Shane, S. (2001). Technological opportunities and new firm creation. Management science, 47(2), 205-220, https://doi.org/10.1287/mnsc.47.2.205.9837.
Shane, S., & Khurana, R. (2003). Bringing individuals back in: the effects of career experience on new firm founding. Industrial and corporate Change, 12(3), 519-543, https://doi.org/10.1093/icc/12.3.519.
Singh, J., & Fleming, L. (2010). Lone inventors as sources of breakthroughs: Myth or reality?. Management science, 56(1), 41-56, https://doi.org/10.1287/mnsc.1090.1072.
Stiller, I., van Witteloostuijn, A., & Cambré, B. (2021). Do current radical innovation measures actually measure radical drug innovation?. Scientometrics, 126(2), 10491078, https://doi.org/10.1007/s11192-020-03778-x.
- U.S. Food and Drug Administration (2020). Advancing Health through Innovation: New Drug Approvals 2020. https://www.fda.gov/media/144982/download.
Paper not yet in RePEc: Add citation now
Wagner, S., & Wakeman, S. (2016). What do patent-based measures tell us about product commercialization? Evidence from the pharmaceutical industry. Research Policy, 45(5), 1091-1102, https://doi.org/10.1016/j.respol.2016.02.006.
- Zhang, H., Shu, C., Jiang, X., & Malter, A. J. (2010). Managing knowledge for innovation: the role of cooperation, competition, and alliance nationality. Journal of International Marketing, 18(4), 74-94, https://doi.org/10.1509/jimk.18.4.74.
Paper not yet in RePEc: Add citation now
- Zidorn, W., & Wagner, M. (2012). The effect of alliances on innovation patterns: an analysis of the biotechnology industry. Industrial and corporate change, 22(6), 14971524, https://doi.org/10.1093/icc/dts042.
Paper not yet in RePEc: Add citation now